BR9813767A - Processo e composição para tratar glaucoma de glc1a - Google Patents

Processo e composição para tratar glaucoma de glc1a

Info

Publication number
BR9813767A
BR9813767A BR9813767-0A BR9813767A BR9813767A BR 9813767 A BR9813767 A BR 9813767A BR 9813767 A BR9813767 A BR 9813767A BR 9813767 A BR9813767 A BR 9813767A
Authority
BR
Brazil
Prior art keywords
composition
glaucoma
treating
glc1a glaucoma
treating glc1a
Prior art date
Application number
BR9813767-0A
Other languages
English (en)
Inventor
John M Yanni
Mark R Hellberg
Original Assignee
Alcon Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Lab Inc filed Critical Alcon Lab Inc
Publication of BR9813767A publication Critical patent/BR9813767A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Abstract

''PROCESSO E COMPOSIçãO PARA TRATAR GLAUCOMA DE GLC1A''. Descreve-se composições de derivados de ácido 3-benzoilfenilacético para tratar o glaucoma de GLC1A e processos para sua utilização.
BR9813767-0A 1997-12-19 1998-12-04 Processo e composição para tratar glaucoma de glc1a BR9813767A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/994,903 US6066671A (en) 1997-12-19 1997-12-19 Treatment of GLC1A glaucoma with 3-benzoyl-phenylacetic acids, esters, or amides
PCT/US1998/025744 WO1999032104A1 (en) 1997-12-19 1998-12-04 Use of 3-benzoyl-phenylacetic acids, esters, or amides for treatment of glc1a glaucoma

Publications (1)

Publication Number Publication Date
BR9813767A true BR9813767A (pt) 2000-10-03

Family

ID=25541199

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9813767-0A BR9813767A (pt) 1997-12-19 1998-12-04 Processo e composição para tratar glaucoma de glc1a

Country Status (13)

Country Link
US (2) US6066671A (pt)
EP (1) EP1039895B1 (pt)
JP (1) JP2001526218A (pt)
AT (1) ATE218336T1 (pt)
AU (1) AU746075C (pt)
BR (1) BR9813767A (pt)
CA (1) CA2313386A1 (pt)
DE (1) DE69805846T2 (pt)
DK (1) DK1039895T3 (pt)
ES (1) ES2178291T3 (pt)
HK (1) HK1027748A1 (pt)
PT (1) PT1039895E (pt)
WO (1) WO1999032104A1 (pt)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7138511B1 (en) 1997-01-28 2006-11-21 The Regents Of The University Of California Nucleic acids, kits and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
US6475724B1 (en) * 1997-01-28 2002-11-05 The Regents Of The University Of California Nucleic acids, kits, and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
US6066671A (en) * 1997-12-19 2000-05-23 Alcon Laboratories, Inc. Treatment of GLC1A glaucoma with 3-benzoyl-phenylacetic acids, esters, or amides
US6646001B2 (en) 1997-12-19 2003-11-11 Alcon Manufacturing, Ltd. Use of non-steroidal anti-inflammatory agents in combination with prostaglandin FP receptor agonists to treat glaucoma and ocular hypertension
US7943162B2 (en) 1999-10-21 2011-05-17 Alcon, Inc. Drug delivery device
ATE283013T1 (de) 1999-10-21 2004-12-15 Alcon Inc Medikamentenzuführvorrichtung
US6416777B1 (en) 1999-10-21 2002-07-09 Alcon Universal Ltd. Ophthalmic drug delivery device
AR030345A1 (es) * 2000-08-14 2003-08-20 Alcon Inc Metodo de tratamiento de desordenes relacionados con angiogenesis
AR030346A1 (es) 2000-08-14 2003-08-20 Alcon Inc Metodo de tratamiento de desordenes neurodegenerativos de la retina y cabeza de nervio optico
AU2002319606B2 (en) 2001-07-23 2006-09-14 Alcon, Inc. Ophthalmic drug delivery device
EP1409065B1 (en) 2001-07-23 2007-01-17 Alcon, Inc. Ophthalmic drug delivery device
US20040132773A1 (en) * 2001-08-13 2004-07-08 Gamache Daniel A Method of treating neurodgenerative disorders of the retina and optic nerve head
US20030119000A1 (en) * 2001-11-05 2003-06-26 Jon Polansky Methods to screen and treat individuals with glaucoma or the propensity to develop glaucoma
KR20040101499A (ko) * 2002-05-03 2004-12-02 알콘, 인코퍼레이티드 암페낙 또는 네파페낙을 이용한 혈관 내피 성장 인자 매개혈관 장애 치료 방법
US6864282B2 (en) 2002-08-05 2005-03-08 Allergan, Inc. 9,11-cycloendoperoxide pro-drugs of prostaglandin analogues for treatment of ocular hypertension and glaucoma
CN100341498C (zh) * 2003-01-21 2007-10-10 千寿制药株式会社 含有2－氨基－3－(4－溴苯甲酰基)苯乙酸的水成液制剂
US20030187072A1 (en) * 2003-02-14 2003-10-02 Kapin Michael A. Method of treating angiogenesis-related disorders
AR043161A1 (es) * 2003-02-14 2005-07-20 Sucampo Pharmaceuticals Inc Composicion oftalmica para tratar hipertension ocular y glaucoma
WO2005014046A2 (en) * 2003-08-07 2005-02-17 Allergan, Inc. Compositions for delivery of therapeutics into the eyes and methods for making and using the same
WO2005044276A1 (ja) * 2003-11-07 2005-05-19 Senju Pharmaceutical Co., Ltd. プロスタグランジン含有医薬組成物
DE602004017477D1 (de) * 2004-11-09 2008-12-11 Novagali Pharma Sa Öl-in-Wasser-Emulsion mit niedriger Konzentration des kationischen Mittels und positivem Zetapotential
TWI358290B (en) * 2004-12-02 2012-02-21 Alcon Inc Topical nepafenac formulations
AU2007223787A1 (en) * 2006-03-08 2007-09-13 Pharmena North America Inc. Combination therapy with non-selective COX inhibitors to prevent COX-related gastric injuries
US20090105245A1 (en) * 2006-12-21 2009-04-23 Bingaman David P Methods for treating macular edema and ocular angiogenesis using an anti-inflammatory agent and a receptor tyrosine kinase inhibitor
US20080153818A1 (en) * 2006-12-21 2008-06-26 Bingaman David P Methods for preventing inflammation during surgery
US20080153819A1 (en) * 2006-12-21 2008-06-26 Bingaman David P Methods for treating macular edema and pathologic ocular angiogenesis using a neuroprotective agent and a receptor tyrosine kinase inhibitor
US20100292289A1 (en) * 2007-11-30 2010-11-18 Ampla Pharmaceuticals Inc. Treatment of metabolic syndrome with novel amides
EP2127638A1 (en) 2008-05-30 2009-12-02 Santen Pharmaceutical Co., Ltd Method and composition for treating ocular hypertension and glaucoma
US8227451B2 (en) * 2008-11-12 2012-07-24 Auspex Pharmaceuticals Phenylacetic acid inhibitors of cyclooxygenase
US20110293549A1 (en) 2009-02-03 2011-12-01 Athena Cosmetics, Inc. Composition, method and kit for enhancing hair
EP2228058A1 (en) 2009-03-04 2010-09-15 Novagali Pharma S.A. Anionic oil-in-water emulsion containing prostaglandins and uses thereof
EP2389939A1 (en) * 2010-05-28 2011-11-30 Novagali Pharma S.A. Use of prostaglandins F2alpha and analogues for the healing of corneal and conjunctival lesions
EP3013790A1 (en) 2013-06-27 2016-05-04 Mylan Laboratories Ltd. Process for the preparation of nepafenac

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA805476B (en) * 1979-09-26 1981-11-25 Robins Co Inc A H 2-amino-3-benzoyl-phenylacetamides and cyclic homologues
US4683242A (en) * 1985-10-28 1987-07-28 A. H. Robins Company, Incorporated Transdermal treatment for pain and inflammation with 2-amino-3-aroylbenzeneacetic acids, salts and esters
US5151444B1 (en) 1987-09-18 1999-07-06 R Tech Ueno Ltd Ocular hypotensive agents
US5565492A (en) 1988-07-18 1996-10-15 Alcon Laboratories, Inc. Prostaglandin combinations in glaucoma therapy
ES2186670T3 (es) 1988-09-06 2003-05-16 Pharmacia Ab Derivados de prostaglandina para el tratamiento del glaucoma o la hipertension ocular.
US5093329A (en) 1990-03-12 1992-03-03 Allergan, Inc. Intraocular pressure reducing prostaglandin-like 7-oxabicyclo derivatives
US5270049A (en) 1990-11-09 1993-12-14 Allergan, Inc. 2-decarboxyl-2-aminoalkyl-prostaglandins as ocular hypotensives
US5510383A (en) 1993-08-03 1996-04-23 Alcon Laboratories, Inc. Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension
US5721273A (en) 1993-12-15 1998-02-24 Alcon Laboratories, Inc. Use of certain 9-halo-13,14-dihydroprostaglandins to treat glaucoma and ocular hypertension
US5627209A (en) 1993-12-15 1997-05-06 Alcon Laboratories, Inc. Use of certain 9-haloprostaglandins to treat glaucoma and ocular hypertension
US5474985A (en) 1993-12-22 1995-12-12 The Regents Of The University Of California Preventing and treating elevated intraocular pressure associated with administered or endogenous steroids using non-steroidal cyclooxygenase inhibitors
US5475034A (en) * 1994-06-06 1995-12-12 Alcon Laboratories, Inc. Topically administrable compositions containing 3-benzoylphenylacetic acid derivatives for treatment of ophthalmic inflammatory disorders
US5807892A (en) 1994-09-30 1998-09-15 Alcon Laboratories, Inc. Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension
US5698733A (en) 1994-09-30 1997-12-16 Alcon Laboratories, Inc. Use of 9-deoxy prostaglandin derivatives to treat glaucoma
CA2201134A1 (en) * 1994-10-10 1996-04-18 Alfred Sallmann Ophthalmic and aural compositions containing diclofenac potassium
US5606043A (en) * 1994-11-03 1997-02-25 The Regents Of The University Of California Methods for the diagnosis of glaucoma
US5925673A (en) 1994-12-23 1999-07-20 Alcon Laboratories, Inc. Benzofurans and benzopyrans as cytoprotective agents
US5607966A (en) 1994-12-23 1997-03-04 Alcon Laboratories, Inc. Esters and amides of non-steroidal anti-inflammatory carboxylic acids which may be used as anti-oxidants, 5-lipoxygenase inhibitors and non-steroidal anti-inflammatory prodrugs
US5599535A (en) 1995-06-07 1997-02-04 Regents Of The University Of California Methods for the cyto-protection of the trabecular meshwork
US5674888A (en) * 1995-06-07 1997-10-07 University Of California Method for the treatment of a trabecular meshwork whose cells are subject to inhibition of cell division
US6169111B1 (en) * 1995-06-07 2001-01-02 Alcon Laboratories, Inc. Conformationally rigid aryl prostaglandins for use in glaucoma therapy
US5750564A (en) 1995-09-12 1998-05-12 Hellberg; Mark Anti-oxidant esters of non-steroidal anti-inflammatory agents
US5866602A (en) 1995-12-22 1999-02-02 Alcon Laboratories, Inc. Keto-substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives
DE69633136T2 (de) 1995-12-22 2005-09-01 Alcon Laboratories, Inc., Fort Worth Substituierte tetrahydrofuran-analoge von prostaglandinen als augendrucksenkende mittel
US5814660A (en) 1995-12-22 1998-09-29 Alcon Laboratories, Inc. 9-oxa prostaglandin analogs as ocular hypotensives
WO1998039293A2 (en) * 1997-03-07 1998-09-11 Alcon Laboratories, Inc. 13-thia prostaglandins for use in glaucoma therapy
US6066671A (en) * 1997-12-19 2000-05-23 Alcon Laboratories, Inc. Treatment of GLC1A glaucoma with 3-benzoyl-phenylacetic acids, esters, or amides
SE9803761D0 (sv) 1998-11-04 1998-11-04 Synphora Ab Method to avoid increased iridial pigmentation during prostaglandin treatment

Also Published As

Publication number Publication date
EP1039895A1 (en) 2000-10-04
AU746075C (en) 2002-10-17
ATE218336T1 (de) 2002-06-15
DE69805846D1 (de) 2002-07-11
US6342524B1 (en) 2002-01-29
US6066671A (en) 2000-05-23
AU1625999A (en) 1999-07-12
ES2178291T3 (es) 2002-12-16
JP2001526218A (ja) 2001-12-18
CA2313386A1 (en) 1999-07-01
HK1027748A1 (en) 2001-01-23
AU746075B2 (en) 2002-04-11
PT1039895E (pt) 2002-10-31
DE69805846T2 (de) 2003-01-16
EP1039895B1 (en) 2002-06-05
DK1039895T3 (da) 2002-09-23
WO1999032104A1 (en) 1999-07-01

Similar Documents

Publication Publication Date Title
BR9813767A (pt) Processo e composição para tratar glaucoma de glc1a
DE69521620D1 (de) Verwendung von 9-deoxyprostaglandinderivaten zur behandlung von glaukom
BR9811099A (pt) Inibidores de urocinase
BR9813684A (pt) Processo para tratar o glaucoma glc1a, e, composição para controlar o glaucoma glc1a.
DE69429524D1 (de) Aminocyclohexylester und ihre anwendung
AU2275397A (en) Troponin subunits and fragments useful as angiogenesis inhibitors
PE106998A1 (es) Composiciones oftalmicas
CA2266759A1 (en) 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase
BR9914848A (pt) Composição e processo para o tratamento de distúrbios da retina externa
AU5355498A (en) 15-fluoro prostaglandins as ocular hypotensives
DE69430521D1 (de) Anwendung von Prostagrandin-Analogen für die Behandlung von Glaukome und okuläre Hypertension
BR0017158A (pt) Agonistas de 5ht2 para controlar a iop e tratar o glaucoma
CA2296560A1 (en) Amino acid derivatives useful to treat stroke
NO982229D0 (no) Svovelholdige di-tert-butylfenol-forbindelser anvendbare som antiinflammatoriske midler
BR9811348A (pt) Compostos derivados de indol, processo para preparação dos mesmos, e, composições farmacêuticas.
CA2192965A1 (en) Anandamide analogue compositions and method of treating intraocular hypertension using same
SE9401087D0 (sv) New prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
DE69736180D1 (de) Behandlung von manischen erkrankungen
BR9807785A (pt) Processo para a preparação do composto, e, composto
ES2190581T3 (es) 2-aminotetralina opticamente activa, procedimiento para su preparacion y composiciones farmaceuticas que la contienen, activa en la prevencion y tratamiento de shock septico.
BR9902081A (pt) Combinação de dofetilida e um bloqueador dos canais de cálcio
BR9809611A (pt) Método para tratar hipertensão sistólica isolada
BR0009862A (pt) Composição tópica para tratar glaucoma ou hipertensão ocular, e, método para tratar glaucoma ou hipertensão ocular
MX9709450A (es) Piridiniminil-1,2-benzoisoxazoles y -benzoisotiazoles como agentes antipsicoticos.

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DE INT.CL.8: A61K 31/165, A61K 31/216, A61K 31/196, A61P 27/06

Ipc: A61K 31/165 (2007.10), A61K 31/216 (2007.10), A61K

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO DE ACORDO COM ART.37, UMA VEZ QUE NAO ATENDE AO ART. 8O E 13 DA LEI 9.279/1996.

B15K Others concerning applications: alteration of classification

Free format text: ALTERADA A INT. CI.6: A61K 31/165, A61K 31/216, A61K 31/196, A61P 27/06

Ipc: A61K 31/165 (2008.04), A61K 31/216 (2008.04), A61K

B12B Appeal against refusal [chapter 12.2 patent gazette]